{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:18:07Z","timestamp":1792671487876,"version":"4.5.0"},"reference-count":71,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"860","funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["NIH\/NINDS 1RO1NS122165-O1"],"award-info":[{"award-number":["NIH\/NINDS 1RO1NS122165-O1"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015439","name":"Centres de Recerca de Catalunya","doi-asserted-by":"publisher","award":["CEX2021-001214-S"],"award-info":[{"award-number":["CEX2021-001214-S"]}],"id":[{"id":"10.13039\/100015439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015439","name":"Centres de Recerca de Catalunya","doi-asserted-by":"publisher","award":["MCIU\/AEI\/10.13039.501100011033"],"award-info":[{"award-number":["MCIU\/AEI\/10.13039.501100011033"]}],"id":[{"id":"10.13039\/100015439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015439","name":"Centres de Recerca de Catalunya","doi-asserted-by":"publisher","award":["MCIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/100015439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/P00119X\/1"],"award-info":[{"award-number":["EP\/P00119X\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/S030719\/1"],"award-info":[{"award-number":["EP\/S030719\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["PGS23\/100184"],"award-info":[{"award-number":["PGS23\/100184"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004264","name":"Robert Luff Foundation","doi-asserted-by":"publisher","award":["PGS23\/100184"],"award-info":[{"award-number":["PGS23\/100184"]}],"id":[{"id":"10.13039\/501100004264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.science.org"],"crossmark-restriction":true},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2026,7,29]]},"abstract":"<jats:p>Resection surgery is the first-line therapy for high-grade glioma performed in &gt;70% of patients with glioblastoma, typically within days of suspected diagnosis. Current protocols for follow-on chemoradiotherapy have shown only modest efficacy in eliminating residual disease, leading to inevitable tumor recurrence. There remains a need for approaches to swiftly and effectively treat postoperative residual disease to prevent the rapid early progression of glioblastoma. Using syngeneic preclinical mouse models of glioblastoma resection, we identified spatially and temporally restricted windows of blood-brain barrier disruption localized to the resection margin during the immediate (0\u00a0hours) and early (48 to 72 hours) postoperative periods. Intravenous administration of fluorescently labeled, clinically used liposomal nanoparticles during these periods revealed selective accumulation at the postoperative resection margin, with minimal penetration into other regions of the brain with an intact blood-brain barrier. Immunohistological analysis confirmed nanoparticle extravasation in the margin parenchyma, largely interacting with microglial and macrophage populations closely associated with residual tumor cells. Exploiting this, we performed intravenous administration of doxorubicin-loaded liposomes coinciding with the peaks of postoperative blood-brain barrier disruption and demonstrated both enhanced chemotherapy delivery to the brain and, consequently, inhibition of tumor recurrence from a single administration across two glioblastoma models. Overall, this work identifies therapeutically exploitable windows of postoperative blood-brain barrier disruption and demonstrates that appropriately coordinated timing can enable clinically used liposomal nanomedicines to be repurposed for early postoperative therapy in aggressive brain tumors.<\/jats:p>","DOI":"10.1126\/scitranslmed.adv8761","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:00:21Z","timestamp":1785348021000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark","source":"Crossref","is-referenced-by-count":4,"title":["Targeting therapeutic nanoparticles to the glioblastoma resection margin by harnessing postoperative blood-brain barrier disruption"],"prefix":"10.1126","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4167-0049","authenticated-orcid":true,"given":"Lorena F.","family":"Fernandes","sequence":"first","affiliation":[{"name":"Centre for Nanotechnology in Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester M13 9PT, UK."},{"name":"Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester M13 9PT, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8419-8221","authenticated-orcid":true,"given":"Chariya","family":"Peeyatu","sequence":"additional","affiliation":[{"name":"Centre for Nanotechnology in Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester M13 9PT, UK."},{"name":"Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester M13 9PT, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4284-3021","authenticated-orcid":true,"given":"Lydia A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Centre for Nanotechnology in Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester M13 9PT, UK."},{"name":"Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester M13 9PT, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben R.","family":"Dickie","sequence":"additional","affiliation":[{"name":"Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester M13 9PT, UK."},{"name":"Division of Informatics, Imaging, and Data Sciences, School of Health Sciences, University of Manchester, Manchester M13 9PT, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Siong","family":"Ho","sequence":"additional","affiliation":[{"name":"Centre for Nanotechnology in Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester M13 9PT, UK."},{"name":"Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester M13 9PT, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-7802","authenticated-orcid":true,"given":"Noelia","family":"Hernandez-Lobato","sequence":"additional","affiliation":[{"name":"Nanomedicine Lab, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, 08193 Barcelona, Spain."},{"name":"Departament de Qu\u00edmica, Facultat de Ci\u00e8ncies, Universitat Aut\u00f2noma de Barcelona, 08193 Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9026-1743","authenticated-orcid":true,"given":"Neus","family":"Lozano","sequence":"additional","affiliation":[{"name":"Nanomedicine Lab, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, 08193 Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-6672","authenticated-orcid":true,"given":"Kostas","family":"Kostarelos","sequence":"additional","affiliation":[{"name":"Centre for Nanotechnology in Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester M13 9PT, UK."},{"name":"Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester M13 9PT, UK."},{"name":"Nanomedicine Lab, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, 08193 Barcelona, Spain."},{"name":"Institute of Neuroscience, Universitat Aut\u00f2noma de Barcelona, 08913 Barcelona, Spain."},{"name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Pg. Llu\u00eds Companys 23, 08010 Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8432-7910","authenticated-orcid":true,"given":"Thomas","family":"Kisby","sequence":"additional","affiliation":[{"name":"Centre for Nanotechnology in Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester M13 9PT, UK."},{"name":"Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester M13 9PT, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21693"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03556-y"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3171\/2021.10.JNS211491"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0177-5"},{"key":"e_1_3_2_7_2","first-page":"vdab053","article-title":"Timing of glioblastoma surgery and patient outcomes: A multicenter cohort study","volume":"3","author":"M\u00fcller D. M.","year":"2021","unstructured":"D. M. M\u00fcller, M. E. De Swart, H. Ardon, F. Barkhof, L. Bello, M. S. Berger, W. Bouwknegt, W. A. Van den Brink, M. Conti Nibali, R. S. Eijgelaar, J. Furtner, S. J. Han, S. Hervey-Jumper, A. J. S. Idema, B. Kiesel, A. Kloet, E. Mandonnet, P. A. J. T. Robe, M. Rossi, T. Sciortino, W. P. Vandertop, M. Visser, M. Wagemakers, G. Widhalm, M. G. Witte, P. C. De Witt Hamer, Timing of glioblastoma surgery and patient outcomes: A multicenter cohort study. Neurooncol. Adv. 3, vdab053 (2021).","journal-title":"Neurooncol. Adv."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov029"},{"key":"e_1_3_2_9_2","first-page":"vdac075","article-title":"Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis","volume":"4","author":"Waqar M.","year":"2022","unstructured":"M. Waqar, F. Roncaroli, E. J. Lehrer, J. D. Palmer, J. Villanueva-Meyer, S. Braunstein, E. Hall, M. Aznar, P. C. De Witt Hamer, P. I. D\u2019Urso, D. Trifiletti, A. Qui\u00f1ones-Hinojosa, P. Wesseling, G. R. Borst, Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis. Neurooncol. Adv. 4, vdac075 (2022).","journal-title":"Neurooncol. Adv."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-016-2362-z"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2511-z"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01020-2"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01157-0"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox175"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3171\/2013.3.JNS122226"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109663"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03231-4"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2016.03.031"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3171\/2014.9.FOCUS14479"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.04.053"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.6143"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.108"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-021-01047-7"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-023-01481-9"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04315-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.11.001"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-021-00946-9"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2024-000573"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b01808"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.72167"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202100722"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2015.1034280"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.3171\/2015.5.JNS142087"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139542"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq1427"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-9574LSF"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou304"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08467-3"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2014.09.002"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05997-1"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq194"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c11578"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-024-01197-4"},{"key":"e_1_3_2_44_2","first-page":"941","article-title":"Doxorubicin-induced cell death in highly invasive human gliomas","volume":"19","author":"Stan A.","year":"1999","unstructured":"A. Stan, S. Casares, D. Radu, G. Walter, T. Brumeanu, Doxorubicin-induced cell death in highly invasive human gliomas. Anticancer Res 19, 941\u2013950 (1999).","journal-title":"Anticancer Res"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004320050305"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00082-B"},{"key":"e_1_3_2_47_2","first-page":"424","article-title":"Pharmacological modulation of blood-brain barrier increases permeability of doxorubicin into the rat brain","volume":"3","author":"Sardi I.","year":"2013","unstructured":"I. Sardi, G. la Marca, S. Cardellicchio, L. Giunti, S. Malvagia, L. Genitori, M. Massimino, M. de Martino, M. G. Giovannini, Pharmacological modulation of blood-brain barrier increases permeability of doxorubicin into the rat brain. Am. J. Cancer Res. 3, 424\u2013432 (2013).","journal-title":"Am. J. Cancer Res."},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20073"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01842886"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1995.83.6.1029"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1459"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.24.18_suppl.11501"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-308"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1215\/S1152851703000188"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2011.02.026"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2014-CT216"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011001)92:7<1936::AID-CNCR1712>3.0.CO;2-H"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2781-0"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c10219"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2017.54"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.08.020"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122851"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.002"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1564-x"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.11.006"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.167313"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-019-03211-1"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.3747\/co.2007.147"},{"key":"e_1_3_2_69_2","first-page":"vdab185","article-title":"GammaTile brachytherapy in the treatment of recurrent glioblastomas","volume":"4","author":"Gessler D. J.","year":"2022","unstructured":"D. J. Gessler, E. C. Neil, R. Shah, J. Levine, J. Shanks, C. Wilke, M. Reynolds, S. Zhang, C. \u00d6z\u00fctemiz, M. Gencturk, M. Folkertsma, W. R. Bell, L. Chen, C. Ferreira, K. Dusenbery, C. C. Chen, GammaTile brachytherapy in the treatment of recurrent glioblastomas. Neurooncol. Adv. 4, vdab185 (2022).","journal-title":"Neurooncol. Adv."},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202201968"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.29840"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrp.2024.102342"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.adv8761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:00:45Z","timestamp":1785348045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.adv8761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":71,"journal-issue":{"issue":"860","published-print":{"date-parts":[[2026,7,29]]}},"alternative-id":["10.1126\/scitranslmed.adv8761"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.adv8761","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"2025-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"eadv8761"}}